19 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
if it is necessary to meet health and safety needs that we are not reasonably satisfying or if it is necessary to meet requirements for public use specified
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
to such intellectual property to third parties under certain specified circumstances, including if it is necessary to meet health and safety needs that we
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
or sublicenses to such intellectual property to third parties under certain specified circumstances, including if it is necessary to meet health and safety needs
S-1/A
EX-1.1
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous
S-1
EX-10.4
iqrh66o6o8hbv6a1wp5
25 Aug 23
IPO registration
5:03pm
S-1
427z1vvf5 x4r5oh
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
injg8v p9usjx18mh
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
v5huyptjy x9j99qy
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.3
rh6cwf
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.2
4w35if7crar4
25 Aug 23
IPO registration
5:03pm
DRS/A
qngc aht3hxyt5r
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
1jv1o9hh11ewp crop
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
wkztj
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
mn1v8rqura9dnbk49ns
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
y8iwoz3kpcniz
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
6k008ba pd
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
s5ciklen sv
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
agkuvumt
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next